Table of Contents

General Information

Keimyung Medical Journal (pISSN: 2092-8335/eISSN: 2733-5380) is the official publication of Keimyung University School of Medicine, a journal published in English. The abbreviation is Keimyung Med J (KMJ). KMJ publishes articles in all medical fields, including clinical research, basic medicine and nursing, with the goal of contributing to the treatment of diseases and promoting human health by sharing the latest information on medical and medical development. KMJ publishes articles on creative and informative original articles, case reports, review articles, and editorials that can encourage and promote medical research. KMJ was first published in 1982, and is published two times a year (June 15 and December 15), and is available for free of charge from the first issue to the latest issue at http://e-kmj.org.

All manuscripts submitted to the KMJ should conform to the following author’s instructions, and if not specified below, must comply with ‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (2023, https://www.icmje.org)’.

Types of Manuscript and Language

The manuscripts submitted to KMJ must be creative and able to contribute to the development of health care, medical services and medical technology, and medical education, including treatment and prevention of diseases. These include original articles, and case reports, review articles (What’s hot?, What’s new?, In-depth review, Clinical practice), editorials. All Manuscripts being submitted must not have been published in other publications, and should not be duplicated in other journals until the end of the review. For the manuscript in the process of review, the author(s) must follow the request of the KMJ editorial board. The language described in the manuscript should be written in English, except in special cases. Academic terms described in the manuscript should use the latest medical terminology published by the Korean Medical Association or the latest terminology in the relevant field.

Research and Publication Ethics

For policies on research and publication ethics not stated in these instructions, “Guidelines on Good Publication Practice by the Committee on Publication Ethics (COPE; http://publicationethics.org/resources/guidelines) or the “Good Publication Practice Guidelines for Medical Journals” by Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/en/main_en) and “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals by the International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org/recommendations/, 2023)”’ can be applied.

1. Authorship

Author qualifications should be meet the following four conditions. 1) a significant contribution in the concept, design, data collection, analysis and interpretation of the manuscript; 2) drafting the article or reviewing it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. After the original manuscript is submitted for the first time, the author's change (adding the author, deleting the author, or reordering the author) must be explained to the editor as a letter from the corresponding author, and all authors' signatures must be attached.

  • • Corresponding author and first author: In principle, there should be only one correspondent author per manuscript. KMJ approves when it is clear that the first author made an equal contribution to the corresponding author in conducting the joint research.
  • • Correction of author after publication: KMJ will not revise the author after publication unless it is an obvious editorial mistake.

2. Redundant Publication and Plagiarism

Redundant publication is defined as reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source. Submitted manuscripts must not been published or be under consideration for publication elsewhere and no part of the accepted manuscript should be duplicated in any other journal without the permission of the Editorial Board. If duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal and their institutes will be informed. There will also be penalties for the authors. The plagiarism will be crosscheck through iThenticate program (https://www.ithenticate.com/) before review.

3. Secondary Publication

Secondary publication may be allowed only with the consent of KMJ editing committee and the journal editing committee that published the original article and in this case, the general requirements of ‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (https://www.icmje.org)’ apply.

4. Conflicts of Interest Statement

The corresponding author must inform the editor of any that could influence the author’s interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to specific companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.

5. Rules and Regulations for Human and Animal Research

If the research involves human subjects, it must comply with the ethical standards of the Helsinki Declaration in 2013 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) and be approved by the Institutional Review Board (IRB). When referring to patients, their identities should not be disclosed or abbreviated. In the case of submitting photographs of patients, their identities should be obscured. If there is even a possibility that the patient’s identity could be revealed, written informed consent must be obtained.
For studies involving animal subjects, regulations relating to the breeding and use of laboratory animals should be observed or the ‘NIH Guide for the Care and Use of Laboratory Animals’. If necessary, approval from the Institutional Animal Care and Use Committee (IACUC) should be obtained.

6. Registration of Clinical Trial Research

Any research that deals with a clinical trial should be registered in the primary national clinical trial registry site, such as the Korea Clinical Research Information Service (CRIS; https://cris.nih.go.kr), any other primary national registry site accredited by the World Health Organization (https://www.who.int/clinical-trials-registry-platform), or ClinicalTrials.gov (https://clinicaltrials.gov/), a service of the US National Institutes of Health.

7. Process to Manage Research and Publication Misconduct

In suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical issues with a submitted manuscript, appropriation of an author’s idea or data, and complaints against editors, the resolving process will be as per the flowchart provided by the Committee on Publication Ethics (https://publicationethics.org/guidance/Flowcharts). The Editorial Board’s decision on the suspected cases will be final.

8. Editorial Responsibilities

Editorial board continuously strives to comply with the publishing ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standard; publishing corrections, clarifications, retractions and apologies when needed; no plagiarism, no fraudulent data. Editors are always keeping following responsibilities: responsibility and authority to rejected/accept article; no conflict of interest respect to articles they reject/accept; acceptance of a paper when reasonably certain; promoting publication of correction or retraction when errors are found; preservation of anonymity of reviewers.

Manuscript review process

1. Submission

All manuscripts should be submitted via the e-submission system available at https://submit.e-kmj.org/. Submission of a manuscripts that it has not been published previously and is not under consideration for publication elsewhere. Also, if accepted, the author(s) must agree that the paper will not be published elsewhere in the same form or in any other language, without written consent of the editorial board.

2. Review process

KMJ reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. The next step is to check for plagiarism or duplication through a similarity check, after confirmation that no ethical violations have been detected, it is peer reviewed by at least two anonymous reviewers selected by the editors. The authors’ names and affiliations are removed during the double-blind peer review.
Acceptance of a manuscript is based on the critiques and recommendations of the reviewers. An initial decision will normally be made within three weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. If choosing to proceed, the corresponding author must indicate all revisions that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within four weeks of the editorial decision is regarded as a withdrawal. If a revision extension period is required, the author should contact the editorial office.
The editorial board notifies the results of the manuscript's deliberation to the corresponding author in one of the following types: accept, minor revision, major revision or reject.
As all editors and Editorial Board members at the KMJ are active professionals and researchers, it may happen that they would want to submit their articles to the KMJ. This represents a potential conflict of interest, especially in cases of submissions from decision-making editors. In reviewing submissions from its editors and Editorial Board members, the KMJ follows the guidelines for good editorial practice set by international editorial organizations, such as World Association of Medical Editors (WAME; http://www.wame.org/resources/publication-ethics-policies-for-medicaljournals#conflicts) and Committee on Publication Ethics (COPE; http://publicationethics.org/case/editor-author-ownjournal). The review of such manuscripts will be processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts although they are commissioned ones.

3. Publication and Printing Process

The editorial board makes the final decision on the publication and order of reviewed manuscripts, which are then printed by the publisher. Authors are required to submit a revised version within two months of receiving the review results notification. However, if more time is needed, permission must be obtained from the publishing director in advance. During the printing process, the corresponding author is responsible for requesting any necessary corrections. It is important to carefully review the manuscript for errors or discrepancies in the title, authorship, affiliation, etc., and ensure compliance with the submission guidelines. Any errors or mistakes discovered after printing are the responsibility of the authors.

4. Appeals of Decisions

The submitter has the right to object to the review and decision results within 7 days of receiving them and can request a review by attaching a reason and submitting it to the editor-in-chief. Upon receiving an objection regarding the paper review and decision results, the editor-in-chief should immediately convene the editorial board to review the raised objection, notify the submitter of the results, and take follow-up measures according to the review decision.
If the reviewer accepts the objection: The editorial board will forward the submitter’s objection to the concerned reviewer to provide a review opinion on the objection and modify the review result accordingly.
If the reviewer doesn’t accept the objection: The editorial board will comprehensively review the reasons for the submitter’s objection and the reviewer’s opinion. If the objection is deemed reasonable, a re-review will be requested after replacing the reviewer.

Copyright, License, Data Sharing

1. Copyright

The copyright for all publications is owned by KMJ and all authors must sign a “Copyright Transfer Agreement” and submit it online through the KMJ electronic submission system. The copyright transfer covers the exclusive right to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.

2. License

KMJ is an Open Access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) that permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Author(s) do not require permission to use any tables or figures published in KMJ in other journals, books, or media for scholarly and educational purposes in accordance with the Budapest Open Access Initiative’s definition of open access.

3. Data Sharing

KMJ accepts the ICMJE Recommendations for data sharing statement policy, unless it is limited to ethics, privacy, or confidentiality issues.

4. Publication Charge (APC)

There is no submission fee or article processing charge. Also, color printing is free. The whole cost occurred during the publication process is provided by the KMJ.

Manuscript Preparation

1. Manuscript Writing

  • 1) The manuscripts can be written in English, except in special cases.
  • 2) The manuscript is written MS Word in A4 (21×30 cm) paper at 10 point fonts in double space texts by leaving 2.5cm space in the right, left, top and bottom sides.
  • 3) The manuscripts should be prepared in the following order: cover page, English abstract, main text (introduction, method, result, discussion, summary), references, table and figure descriptions, tables, and figures. Each part starts with a new one.
  • 4) Academic terms should be used based on medical glossaries published by the Korean Medical Association. If there is a translation but it is difficult to convey the meaning, write the original in parentheses after the translation when the translation is used for the first time, After that, only the translations should be described.
    Academic terms, proper nouns, place names, person names, drug names, units, etc. without proper translation may be written directly in the original language.
  • 5) If you must use an abbreviation, use the abbreviation in parentheses after the first term. Only use the abbreviation for future use.
  • 6) Arabic numerals are used for numbers, and metric system for weights and measures. All units should use International Standard (SI) units in principle.

2. Cover page

  • 1) The cover page should include the manuscript type, title, author's name and affiliation.
    If there are authors with different affiliations, record the main research institute first, and then write the same shoulder number in the author's name and the affiliation, in the order of the author's name.
  • 2) The title should reflect the intent and content of the manuscript.
    Korean title should not exceed 40 words and English title should not exceed 20 words. The first letter of the English word is capitalized.
  • 3) At the bottom of the cover, write the name, affiliation, address, and contact information of the corresponding author, and related matters such as the grant of research funds and the presentation of the conference.

3. Abstract

  • 1) English abstract should be written without paragraph division and should not exceed 250 words.
  • 2) Keywords can be listed up to 5 at the bottom of the abstract and refer to the Medical Subject Headings (MeSH) provided by the National Library of Medicine.

4. Main text

  • 1) The original articles should be described in the order of introduction, materials and methods (objects and methods), results, discussion, acknowledgment, and conflict of Interest.
  • 2) The case reports should be in the order of introduction, consideration, discussion, acknowledgment, and conflict of interests.
  • 3) The review article is commissioned by the editorial board for publication. The format of a review article allows for flexibility in content.
  • 4) Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.

5. References

  • 1) References should be cited in the text and written in English in the order in which they are cited.
  • 2) The author's name should be written with family names and the name should be abbreviated.
  • 3) If there are six or fewer authors, write all author names. If there are more than six authors, write the names of up to six authors and replace them with ‘et al.’.
  • 4) Journal names should use the recognized abbreviation of Index Medicus.
  • 5) References in the main text should be numbered in square brackets in sequential order. Numbers should be written after the author's last name or, if there is no author's last name, before the period or comma in the sentence. When there are two or less authors, the author's last name is used. When there are three or more authors, use the first author followed by ‘et al.’
  • 6) References not specified below are described in the “Citing Medicine (2nd edition)” from the National Library of Medicine (http://www.nlm.nih.gov/citingmedicine).

Reference method is based on the following example.

Journal Article:

  • 1. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol. 2005;22:51-68.
  • 2. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of america. Clin Infect Dis. 2008;46:327-60.

Electronic Journal Article:

Book:

  • 4. Rosai J, Ackerman LV. Rosai and Ackerman's surgical pathology. 9th ed. Mosby; 2004.

Book Section:

  • 5. Zipfel GJ, Day AL. Surgical treatment of intracavernous and paraclinoid internal carotid artery aneurysm. In: Winn HR, editor. Youmans Neurological Surgery. 5th ed. W.B.Saunders; 2004. p.1895-913.

Web Page:

6. Tables

  • 1) Tables should be arranged in order only those mentioned in the text and numbered Arabic numerals.
  • 2) Tables should be written in English and capitalize only the first letter in the title and legend on the horizontal and vertical axes.
  • 3) The title of the table should appear at the top of the table in the form of a clause or phrase.
  • 4) The table uses only the horizontal solid line of the vertical line, not the vertical line.
  • 5) When referring to a specific table in the text, write ‘Table 1’.
  • 6) When using the abbreviation, explain it at the bottom.

7. Figures

  • 1) The figures are listed and numbered in the order in which they are mentioned in the text.
  • 2) The figures should be clear, with a size of 15 x 20 cm or less, a capacity of 5 MB or less, and a resolution of 300 dpi or more recommended and accept as ppt, jpg, and tif files.
  • 3) In the case of two or more figures of the same number, mark the letters A, B, and C after Arabic numerals.
  • 4) When referring to a specific figure in the text, ‘Fig. 1’ is written.
  • 5) Line drawing should in principle be original. When citing pictures from other papers, in principle, the original author's consent should be obtained.

8. Others

Matters not mentioned in this submission rule are in accordance with general practice.
Copyright© Keimyung University School of Medicine.
Editorial Office
1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Korea
Tel: +82-53-258-7582   Fax: +82-53-258-7589   E-mail: tinlib@dsmc.or.kr      Privacy Policy      Developed in M2PI